Genomic therapy developer EdiGene, electric vehicle rental platform Go Sharing and API management platform developer RapidAPI have all raised about $60m.

Funding China-headquartered genomic drug developer EdiGene has closed a RMB400m ($61.6m) series B-plus round featuring Lilly Asia Ventures, a corporate venturing vehicle for pharmaceutical firm Eli Lilly. The round was led by Loyal Valley Capital and included BioTrack Capital, Sherpa Healthcare Partners and existing backers including IDG Capital, 3H Health Investment, Huagai Capital, Sequoia Capital…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.